Dignitana kompletterar den tidigare aviserade riktade emissionen med ytterligare en riktad emission

Dignitana complements the previously announced directed rights issue – decides on an additional directed rights issue

Dignitana AB Publishes Information Memorandum

Dignitana offentliggör Informations-Memorandum

Dignitana CEO William Cronin will present a company overview in Stockholm on Tuesday 4 December. Register here:

Load More...


7 hours ago


'Researchers Say They’ve Created Universal #Cancer Test That Detects Mutating Cells in Just 10 Minutes' - The tool—newly detailed in Nature Communications—is still in the earliest stages of development, meaning you likely won’t be seeing it in your doctor’s office anytime soon. - Smithsonian ...

View on Facebook

23 hours ago


"I had great success with using DigniCap! This saved me from the extra mental anguish that comes with having breast cancer” - “Areka Phillips ...

View on Facebook

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90